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Abstract 
The method of making alginate-poly-L-lysine microcapsules for hybridoma cell culture 
can be simplified by cultivating the cells in RPM1 1640 medium. Phosphate concentration 
in RPM1 1640 medium is sufficiently high to dissolve the alginate gel and, thereby, can be 
used to eliminate the step of citrate buffer treatment required for reliquefying the interior 
al&ate gel. 
INTRODUCTION 
Among various efficient cell culture systems, the encapsulation of living cells within alginate-poly-l- 
lysine (PLL) membrane has received much attention as a means of improving the production of desirable 
cellular products. This method, which was successfully demonstrated by Lim and Moss in 1979, was 
primarily developed to transplant living cells without an in oivo rejection reaction (Lim and Sun, 1980; 
Lim and Moss, 1981). Damon Biotech has employed this process (ENCAPCEL) to grow a number of cell 
types including hybridoma cells and genetically engineered cells and has shown that microencapsulation 
of hybridoma cells has advantages in production and purification of monoclonal antibodies (Rupp, 1985; 
Posillico, 1986; Nilsson, 1987). Overall, the microencapsulated cell system has several advantages when 
compared to a free cell system. First, microcapsules are much larger than free cells and their use in 
perfusion systems is much easier. Second, direct sparging of gases into a bioreactor is permitted since 
cells are protected from physical shear inside microcapsules. Third, the product can be partitioned into 
either the microcapsules or the medium. However, the current technique of producing the microcapsules 
is complex and it involves many steps: the formation of alginate beads, treatment of PLL, liquefaction 
of the inner core of the alginate beads using citrate buffer and several washing steps (Lim and Sun, 1980; 
Lim and Moss, 1981; Lim, 1984; Goosen et al., 1985). 
In this article, we show that this method can be simplified by cultivating cells in RPM1 1640 medium 
which is one of the typical basal media (Adamson et al., 1987). 
MATERIALS AND METHODS 
Cell line, medium and culture maintenance 
The murine hybridoma used was S3H5/y2bA2, provided by Dr. Mark Kaminski from the University 
of Michigan Medical Center. The antibody produced by this cell line is y2bA anti-idiotype antibody, 
directed against the 38C13. 
The cells were grown in RPM1 1640 (Sigma, St.Louis, MO) supplemented with 10% fetal bovine serum 
(Gibco Laboratories, Grand Island, NY) and 100 units of penicillin/ml and 100 pg of streptomycin/ml 
(Sigma). 
The cells were maintained in T 25 cm2 plastic cell culture flasks (Bellco Glass, Inc., Vineland, NJ) 
at 37OC in a CO, incubator. 
Immobilization 
Hybridoma cells were entrapped in a gel matrix of calcium alginate as shown in Figure 1. This 
is the modified procedure described by Posillico et al. (1987). (1) Exponentially growing cells (cell 
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Figure 1: The microencapsulation process 
densityZl.7.10” cells/ml) were centrfuged at 1000 rpm for 10 min. After discarding the supernatant, 
cells were suspended in buffered saline (O.g%(w/v)) NaCl buffered with 2.2 mM HEPES (pH 7.4 and 
15Omg glucose/l)) and were centrifuged again. After decanting the supernatant, the cell pellet remaining 
at the bottom of the centrifuge tube was then resuspended in alginate solution (1.5%w/v in 0.85% 
NaCl). The final cell concentration was approximately 4.10s cells/ml in 1.5% sodium alginate (Keltone 
LV, Kelco, Chicago, IL). A mixture of viable cells and alginate solution was packed in a syringe. (2) The 
mixture was extruded dropwisc into I.~%(w/v) C a Cl z solution using an air-syringe droplet generator 
(Lim, 1984). Uniform sized gel particle (0.8-1.0 mm in diameter) were obtained in this manner. Gel- 
entrapped hybridoma cells were allowed to stand for 10 minutes in order to achieve proper gelation. 
(4) The supernatant solution was removed by decantation, and the immobilized cells were washed 3 
times with buffered saline. Gel particles were resuspended in O.OS%(w/v) poly-L-lysine (PLL, molecular 
weight 22,000, Sigma) for 6 minutes to form the membrane. After washing the gel particles twice, the gel 
particle were resuspended in 0.06% sodium alginate to tie up any uncomplexed amino acids groups on 
the poly amino acid molecules.. The supernatant solution was removed by decantation, and immobilized 
cells were washed three times with fresh media. Finally, the immobilized cells were transferred to lOOm1 
spinner flasks (B&co). 
Cell culture 
Immobilized cell cultures were performed in a spinner flask at a agitation speed of 50 rpm. 10 ml 
of immobilized cells was inoculated into 90 ml of RPM1 1640 media containing 10% FBS. Medium was 
changed daily. Cell cultures were performed at 37°C in a COs incubator (5% COz). Cell growth was 
monitored using photomicrography. 
RESULTS AND DISCUSSION 
The ENCAPCEL process begins with the suspension of hybridoma cells in a sodium alginate solution. 
This suspension is extruded dropwise into a CaClz solution. The CaZt ions react instantly with the 
negatively charged al&ate molecules thereby forming gelled microbeads containing the entrapped cells. 
Next, the cell-containing microbeads are treated with a PLL solution possessing complementary charges 
to those of alginate. In this membrane-forming step, the positively charged amino groups of the polyamino 
acid replace the surface layer of calcium ion in the gel beads. This treatment results in the formation of 
a polysalt hydrogel membrane on the surface of the microbe.&. This polyelectrolyte complex is more 
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Table 1: Phosphate and calcium concentration in media (Freshney el al., 1987). 
Components RPM1 Eagle’s Dulbecco’s Ham’s CMRL 
(w/l) 1640 MEM modification F12 1066 199 L15 Fischer’s IMDM 
CaCla 200 200 200 - - - 
CaCls.2HsO - - 44 - 186 186 91 219 
NaHsPOI.HsO - 140 125 140 - - 78 
NasHPOl 47.5 190 60 109 
NasHPOl.7Ha0 1512 - 268 - - - - 
KHzPO, - - 60 60 - 
stable than the Ca2+ alginate gel. Finally, the interior calcium alginate gel is liquefied by removal of 
calcium ions with a mild chelating agent such as aqueous sodium citrate. Since only the interior of treated 
gel beads is Ca2+ alginate, the sodium citrate treatment creates capsules with a liquid core surrounded 
by a PLL- alginate gel membrane. 
The final step of reliquefying the calcium alginate gel can be eliminated by cultivating entrapped 
cells in RPhfI 1640 medium. As shown in Table 1, phosphate concentration in RPM1 1640 (1512 mg/l) 
is much higher than that of any other basal media. Phosphate is one of the calcium chelating agents 
and its concentration in RPM1 1640 medium is high enough to dissolve the calcium alginate gel. In 
addition, there is no calcium chloride in RPM1 1640 medium which would stabilize the calcium alginate 
gel. Therefore, after the membrane (PLL-alginate) forming step, beads containing the cells can be 
directly transferred to RPM1 1640 medium without liquefying the interior calcium alginate gel, which is 
required when the other basal media are used. 
As shown in Figure 2, cells were cultivated in beads and the beads became microcapsules within one 
day of presence in RPM1 1640 medium. Cells reached close to packing density inside the capsules after 
3 weeks of cultivation. Since beads are more rigid than microcapsules, it is easier to handle beads than 
microcapsules for transfer and start-up of a reactor. RPM1 1640 medium is known to be as good as other 
basal media in the respect of cell growth and MAb production (Adamson et al., 1987). For instance, 
S3H5/y2bA2, the cell line used in this experiment, showed higher specific growth rate in RPM1 1640 
medium than in Iscove’s Modified Dulbecco’s Medium (IMDM) (Savinell et al., 1989). 
In conclusion, the step of citrate buffer treatment required for reliquefying the interior alginate gel 
can be eliminated by cultivating the cells in RPM11640 medium. 
ACKNOWLEDGEMENT The authors thank Dr. hlark Kaminski for supplying the cell line and 
Kelco for supplying alginate. This work was supported by National Science Foundation. (EET-8712756). 
343 
Figure 2: The PWcrographa of hybridoma cell growth in capm& 
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